Vertebroplasty Surgery in India
Get Vertebroplasty Surgery at internationally accredited (JCI/NABH) Indian hospitals at a fraction of Western costs, with end-to-end international patient support — visa, travel, stay, and follow-up care.
Vertebroplasty Surgery in UAE
Vertebroplasty Surgery at leading UAE hospitals in Dubai and Abu Dhabi — world-class care closer to home, visa-free entry for many nationalities, international specialists, and modern facilities.
Overview
Vertebroplasty is a minimally invasive interventional procedure in which medical-grade polymethylmethacrylate (PMMA) bone cement is percutaneously injected under fluoroscopic or CT guidance into a fractured or collapsed vertebral body, restoring structural integrity and providing rapid pain relief — with clinical studies reporting pain reduction in 80–90% of appropriately selected patients within 24–72 hours. International patients increasingly choose India and the UAE for this procedure due to the combination of world-class interventional radiology and spine surgery infrastructure, internationally accredited hospitals, and dramatically lower out-of-pocket costs compared to the United States, United Kingdom, or Australia. GAF Healthcare (gaf.healthcare) coordinates the full care pathway — from specialist second opinions and pre-procedure imaging review to visa facilitation, hospital placement, and post-procedure rehabilitation — making access to high-quality vertebroplasty seamless for patients traveling from across the globe.
Hospital Stay: 1–2 days (procedure is typically performed under local anaesthesia with conscious sedation; most patients are discharged the same day or the following morning) • Total Stay in Country (Fit-to-Fly): 1–2 weeks (short-haul flights of under 4 hours may be permitted after 5–7 days; long-haul intercontinental flights are generally safe after 10–14 days, subject to the treating physician's clearance and absence of complications such as cement pulmonary embolism or adjacent-level fracture) • Success Rate: 85–90% (defined as clinically significant pain reduction of ≥50% on the Visual Analogue Scale [VAS] with restored ambulatory function, consistent with outcomes published in the New England Journal of Medicine, SPINE journal, and Cochrane systematic reviews for acute osteoporotic and malignant vertebral compression fractures)
What Is It?
Vertebral compression fractures (VCFs) represent one of the most prevalent skeletal consequences of osteoporosis, affecting an estimated 1.4 million people worldwide annually, though the condition also arises from osteolytic spinal metastases (most commonly from breast, prostate, lung, renal cell, and multiple myeloma primaries), vertebral haemangiomas, and traumatic injury in younger patients. Biomechanically, a VCF results in loss of vertebral body height — often greater than 15–20% — leading to progressive kyphotic deformity, altered spinal load distribution, compromise of adjacent disc levels, restrictive pulmonary dysfunction from thoracic cage compression, and debilitating axial back pain that severely limits mobility and quality of life. Neurological deficits, while less common in pure osteoporotic VCF, can emerge when retropulsed bony fragments encroach upon the spinal canal, a finding that must be systematically excluded before vertebroplasty candidacy is confirmed.
The physiological rationale for vertebroplasty rests on two concurrent mechanisms: mechanical stabilisation of the fractured trabeculae by the polymerising PMMA cement (which achieves compressive strength comparable to native cancellous bone), and a neurochemical analgesic effect attributed to thermal necrosis of intraosseous nociceptors during the cement's exothermic curing process. Modern procedural refinements — including the use of high-viscosity cement formulations, real-time biplanar fluoroscopy, and cone-beam CT (CBCT) intraoperative imaging — have substantially reduced the rate of clinically significant cement extravasation, historically the procedure's most consequential complication.
The evidence base for vertebroplasty has evolved considerably since two sham-controlled randomised trials (Buchbinder et al., NEJM 2009; Kallmes et al., NEJM 2009) raised methodological questions about its efficacy. Subsequent high-quality trials — most notably the VERTOS IV trial (Lancet, 2018) — demonstrated statistically and clinically significant superiority of vertebroplasty over sham procedure in patients with acute, oedematous (MRI bone marrow oedema–positive) VCFs of less than 6 weeks' duration, effectively refining the patient selection criteria that define current best practice. Centres of excellence in India and the UAE adhere rigorously to these evidence-based selection protocols, ensuring that vertebroplasty is offered only to patients with the highest probability of meaningful clinical benefit.
Candidates
IDEAL CANDIDATES — INCLUSION CRITERIA:
• Painful osteoporotic vertebral compression fracture with MRI-confirmed bone marrow oedema (STIR/fat-suppressed T2 hyperintensity), indicating an acute or subacute fracture (typically ≤6–8 weeks old)
• Fracture-related pain score ≥5/10 on the Visual Analogue Scale (VAS) that is refractory to optimised conservative management (bed rest, analgesics including NSAIDs and opioids, bracing) for a minimum of 3–6 weeks
• Patients with osteolytic vertebral metastases causing intractable pain, with or without pathological fracture, where systemic oncological therapy (radiotherapy, bisphosphonates, denosumab) has failed or is insufficient for pain control
• Symptomatic vertebral haemangiomas with local pain and/or mild neurological involvement
• Vertebral body collapse of up to 70–75% of original height (greater collapse may preclude adequate cement fill)
• Acceptable surgical risk as assessed by ASA Physical Status Classification (typically ASA I–III); vertebroplasty is uniquely suitable for high-risk operative candidates unfit for open spinal surgery
REQUIRED PRE-PROCEDURE DIAGNOSTICS:
• MRI Spine (whole spine survey preferred): mandatory to confirm marrow oedema, assess canal compromise, identify multilevel disease, and rule out posterior element involvement
• CT Spine (targeted to the level of interest): defines cortical integrity, posterior wall breach, and pedicle anatomy for safe needle trajectory planning
• DEXA (Dual-Energy X-ray Absorptiometry): quantifies bone mineral density (BMD); T-score ≤−2.5 confirms osteoporosis aetiology
• Bone scintigraphy (Tc-99m) or PET-CT (18F-FDG): recommended when metastatic or malignant aetiology is suspected to map disease burden and guide biopsy targeting
• Full blood panel: CBC, coagulation profile (PT/INR, aPTT), renal function (eGFR, serum creatinine — relevant for contrast use in CT guidance), serum calcium, alkaline phosphatase, tumour markers (PSA, CA-125, CEA as clinically indicated)
• Cardiopulmonary evaluation (ECG, Echocardiogram/ECHO if clinically indicated) for pre-anaesthesia clearance
• Bone biopsy (coaxial, performed concurrently via the vertebroplasty needle): mandatory when malignant aetiology is suspected and no prior histological diagnosis exists
CONTRAINDICATIONS:
• Absolute: Active spinal or systemic infection (osteomyelitis, epidural abscess, discitis, bacteraemia); significant posterior vertebral wall disruption with canal compromise and neurological deficit (relative contraindication — may require surgical decompression first); coagulopathy uncorrectable to INR <1.5 and platelet count >50,000/µL; allergy to PMMA cement components or opacification agents (barium sulphate/tantalum)
• Relative: Severe vertebral body collapse (>75%) with inability to establish safe transpedicular or parapedicular needle access; purely ligamentous or discogenic pain without osseous pathology; asymptomatic fractures; patients with uncorrected coagulopathy; pregnancy
Procedure
STANDARD VERTEBROPLASTY (Percutaneous Fluoroscopy-Guided): The foundational technique involves placement of an 11–13-gauge bevelled trocar needle via a transpedicular or extrapedicular (parapedicular/intercostovertebral) approach under biplanar fluoroscopic guidance, with the patient in prone position under local anaesthesia and conscious sedation (intravenous midazolam and fentanyl). Once the needle tip is confirmed in the anterior third of the vertebral body, low-viscosity PMMA cement mixed with barium sulphate (for radio-opacity) is slowly injected in 0.5–1.0 mL aliquots under continuous real-time fluoroscopic monitoring until adequate vertebral body fill is achieved (typically 2–6 mL per level) or cement approaches the posterior cortex. The procedure is most commonly performed at 1–3 levels per session.
KYPHOPLASTY (Balloon-Assisted Vertebroplasty — Advanced Technique): Kyphoplasty is a closely related but technically distinct augmentation procedure in which a bilateral transpedicular approach is used to introduce an inflatable bone tamp (IBT) into the vertebral body. Sequential balloon inflation under manometric control (up to 220–400 psi) attempts to restore vertebral height (mean height restoration: 34–47% of lost height, per published literature) and create a low-pressure cavity prior to cement injection. The cavity allows use of higher-viscosity cement, reducing extravasation risk. Kyphoplasty is preferred in: (a) fractures with significant height loss and kyphotic angulation where height restoration is a clinical goal; (b) thoracolumbar junction fractures (T10–L2) where biomechanical correction reduces adjacent-segment stress; (c) patients with posterior wall compromise where controlled cavity creation and high-viscosity cement offer added safety. Major kyphoplasty systems in use at leading centres include Medtronic's KyphX Xpander IBT system and Stryker's AVAflex system.
CT-GUIDED VERTEBROPLASTY: Cone-beam CT (CBCT) or conventional CT-guided vertebroplasty is employed when fluoroscopy alone provides inadequate visualisation — particularly for cervical vertebroplasty (C2–C7), which requires specialised anterolateral or posterolateral needle trajectories, and for mid-thoracic levels (T3–T6) where overlapping rib and mediastinal anatomy obscures fluoroscopic views. CT guidance enables sub-millimetre needle tip localisation and real-time 3D visualisation of cement distribution, making it the preferred modality for high-risk or complex cases at advanced centres in India and the UAE.
COMBINED VERTEBROPLASTY WITH RADIOFREQUENCY ABLATION (RFA): For painful vertebral metastases, vertebroplasty is increasingly performed in tandem with radiofrequency ablation (RFA) or cryoablation of the tumour mass prior to cement injection. This combined approach (SteriTaxis, STAR Tumour Ablation System by Merit Medical) achieves simultaneous tumour cytoreduction, direct neurochemical analgesia, and mechanical stabilisation. Evidence from prospective studies (e.g., Hoffmann et al., Radiology 2018) supports superior pain control compared to vertebroplasty alone in the metastatic setting.
STAVE (Skyphoplasty/Spine Jack Vertebroplasty — Next-Generation Restoration): The Spine Jack device (Vexim/Stryker) and similar implantable titanium expandable stents represent the latest evolution, offering controlled, symmetric vertebral body height restoration without the need for balloon inflation, followed by cement injection through the hollow implant. These devices are available at select JCI-accredited tertiary centres in India (Mumbai, Delhi, Chennai) and the UAE (Dubai, Abu Dhabi) and are particularly indicated for traumatic burst fractures and severe osteoporotic collapses in younger patients.
MULTI-LEVEL VERTEBROPLASTY: Up to 3–4 levels are routinely treated in a single session at high-volume centres. For patients with widespread metastatic disease requiring treatment of 5 or more levels, staged procedures (separated by 2–4 weeks) are standard of care to limit total cement volume, procedural time, and radiation exposure.
ADJUNCT PHARMACOTHERAPY (Pre- and Post-Procedure): Osteoporotic patients require concurrent optimisation of bone health: initiation or continuation of anti-resorptive therapy (bisphosphonates — zoledronic acid IV annually, or oral alendronate/risedronate weekly) or anabolic therapy (teriparatide/abaloparatide for 18–24 months, or romosozumab for 12 months) is essential to prevent subsequent fractures. In the metastatic setting, denosumab (Xgeva 120 mg SC monthly) or zoledronic acid (4 mg IV every 3–4 weeks) reduces skeletal-related events.
Cost of Vertebroplasty Surgery: India vs. UAE
The cost of vertebroplasty surgery varies significantly between India, the UAE, and Western healthcare systems. Both India and the UAE offer internationally accredited care at a fraction of the cost charged in the United States (where a single-level vertebroplasty or kyphoplasty typically costs USD 15,000–35,000) or the United Kingdom under private care. India offers the most cost-efficient pathway — typically 40–60% less expensive than the UAE — while the UAE appeals to patients who prioritise ultra-premium hospital environments, proximity (particularly for Middle Eastern and African patients), and seamless business-class medical travel. The estimates below cover the surgical procedure, standard hospital admission (1–2 nights), anaesthesia, intraoperative imaging, PMMA cement and consumables, and routine post-operative medications. They do not include international flights, pre-procedure diagnostics performed abroad, or extended physiotherapy packages.
| Destination | Estimated Cost (USD) | Key Advantage |
|---|---|---|
| India | $2,500 – $5,500 | ~52% less than the UAE |
| UAE (Dubai/Abu Dhabi) | $5,500 – $11,000 | Premium care, JCI/DHA accredited |
Estimates typically include surgery, hospital stay, and standard medications. Contact us for a personalised quote.
Recovery & Aftercare
PRE-PROCEDURE PHASE (Days −14 to −1):
• Day −14 to −7: GAF Healthcare coordinates a remote pre-assessment. The patient submits all existing imaging (MRI, CT, X-rays) and blood work via the GAF secure portal for review by the assigned interventional radiologist or spine surgeon at the chosen hospital in India or the UAE. A written specialist opinion with procedure recommendation and cost estimate is provided within 48–72 hours.
• Day −7: Visa facilitation initiated. For India: e-Medical Visa application submitted with GAF's support (hospital invitation letter, specialist appointment confirmation). For UAE: Entry visa or visa-on-arrival arrangements confirmed per the patient's nationality.
• Day −3 to −2: Patient arrives in destination country. GAF airport transfer team receives patient and attendant. Check-in to GAF-partnered accommodation (hospital guesthouse or nearby serviced apartment).
• Day −1: Pre-admission workup at hospital. Repeat MRI review by interventional radiologist. Anaesthesia pre-assessment. Blood tests (coagulation, renal function, CBC). Nil by mouth (NPO) instructions from midnight. Anticoagulants (warfarin, novel oral anticoagulants — NOACs, low molecular weight heparin) bridged or withheld as per standardised protocols (typically warfarin held for 5 days targeting INR <1.5; NOACs held for 24–48 hours).
PROCEDURE DAY:
• Morning: IV access established. Prophylactic IV antibiotics administered (cefazolin 1–2g or clindamycin if penicillin-allergic) 30 minutes before needle insertion.
• Positioning: Patient placed prone on a radiolucent operating/fluoroscopy table with bolsters under the chest and iliac crests to allow thoracolumbar extension.
• Anaesthesia: Conscious sedation (IV midazolam + fentanyl ± propofol infusion) with local anaesthetic infiltration (1% lignocaine) along needle tract to periosteum. General anaesthesia is reserved for paediatric patients, severe anxiety, or complex multilevel procedures.
• Procedure: Biplanar fluoroscopy or CT guidance used to navigate the trocar needle transpedicularly into the anterior third of the vertebral body. For kyphoplasty, balloon catheters inserted bilaterally, inflated sequentially under fluoroscopic and manometric monitoring, then deflated and removed. PMMA cement (premixed with barium sulphate to viscous, toothpaste-like consistency) injected slowly in real-time under continuous fluoroscopic surveillance. Cement injection halted immediately if extravasation toward posterior wall, epidural space, or paravertebral veins is observed. Needle removed after cement hardens (3–5 minutes). Sterile dressing applied.
• Duration: Single-level vertebroplasty: 30–45 minutes. Single-level kyphoplasty: 45–75 minutes. Two-level procedure: approximately 60–90 minutes.
• Post-procedure: Patient transferred to recovery room. Vital signs, neurological status, and pain score monitored for 2–4 hours. CT scan of treated levels performed immediately post-procedure at most centres to document cement distribution and exclude significant extravasation.
POST-PROCEDURE RECOVERY MILESTONES:
• Hour 2–4: Patient mobilised to standing and ambulation with physiotherapist assistance. VAS pain score typically drops from baseline 7–9/10 to 2–4/10 within this window. Oral analgesics commenced (paracetamol, low-dose NSAIDs or tramadol as required).
• Day 1 (Post-op Day 1): Final neurological assessment by treating physician. Discharge planning confirmed. Patients are advised to avoid heavy lifting (>5 kg), bending, and twisting for 6 weeks.
• Day 2–3: Outpatient physiotherapy session. Back bracing (thoracolumbar orthosis / TLSO) fitting if indicated for osteoporotic patients with multilevel disease or residual kyphosis.
• Week 1–2: Follow-up consultation (in-person or telemedicine via GAF platform) with the interventional radiologist. Wound inspection. Commencement or optimisation of anti-osteoporosis pharmacotherapy. Pain VAS reassessment. Fit-to-fly clearance issued by treating physician — typically granted at Day 7–10 for short-haul travel and Day 10–14 for long-haul intercontinental flights.
• Week 4–6: Structured physiotherapy and core stabilisation exercise programme under GAF-coordinated remote physiotherapy. Gradual return to normal daily activities.
• Month 3: Follow-up MRI or CT spine to assess cement consolidation, adjacent-level fracture surveillance (the most important medium-term complication), and bone density response to pharmacotherapy.
• Month 6–12: DEXA scan to monitor BMD response to anti-osteoporosis therapy. Oncology review (if metastatic aetiology) with PET-CT as indicated.
Risks & Considerations
Vertebroplasty is among the safest procedures in interventional spine care, but patients and referring physicians must be counselled on the following specific risks with honest probability estimates drawn from peer-reviewed evidence:
CEMENT EXTRAVASATION (most common complication): Reported in 20–73% of procedures on imaging, but clinically significant extravasation causing symptoms occurs in only 1–3% of cases. Routes of leakage include: paravertebral soft tissue (usually inconsequential), epidural space (risk of spinal cord or nerve root compression — most serious), intervertebral disc space (associated with accelerated adjacent disc degeneration), and basivertebral or segmental veins (risk of pulmonary cement embolism). High-viscosity cement, biplanar fluoroscopy, and CBCT monitoring at experienced centres have reduced symptomatic extravasation rates to under 1%.
Top Hospitals for Vertebroplasty Surgery
Frequently Asked Questions — Vertebroplasty Surgery
The cost of vertebroplasty surgery in India typically ranges from USD 2,500 to USD 5,500 for a single-level procedure, inclusive of the hospital admission (1–2 nights), surgeon and anaesthetist fees, intraoperative fluoroscopy or CT guidance, PMMA cement and procedural consumables, and standard post-operative medications. Kyphoplasty — the balloon-assisted variant — and multilevel procedures (2–3 levels) are priced at the higher end of this range. In the UAE (Dubai or Abu Dhabi), the equivalent procedure at a JCI-accredited hospital costs approximately USD 5,500 to USD 11,000, reflecting the higher operating costs of the UAE healthcare infrastructure, premium nursing ratios, and luxury private room standards. By comparison, a single-level vertebroplasty or kyphoplasty in the United States typically costs USD 15,000–35,000 under private insurance or self-pay. Both India and the UAE represent substantial cost savings without compromise to clinical quality. GAF Healthcare provides a transparent, itemised cost estimate specific to the patient's fracture level, number of levels to be treated, preferred hospital, and room category before any commitment is made.
Most patients undergoing vertebroplasty are discharged from hospital on the same day or the morning after the procedure (1–2 day hospital stay). However, air travel — particularly long-haul intercontinental flights — requires an additional observation period to ensure the absence of early complications, including clinically significant cement extravasation, pulmonary cement embolism, adjacent-level fracture, or neurological changes. As a general guideline: short-haul flights (under 4 hours) are typically cleared at Day 5–7 post-procedure, provided the patient is ambulatory, pain is well controlled on oral analgesics, and a post-procedure CT confirms satisfactory cement placement without significant extravasation. Long-haul intercontinental flights (over 4–6 hours) are cleared at Day 10–14 post-procedure. GAF Healthcare strongly advises all patients to obtain written fit-to-fly clearance from their treating physician before booking return travel. We recommend planning a minimum in-country stay of 10–14 days to allow for pre-procedure workup (1–2 days), the procedure itself (1–2 days hospitalisation), and the post-discharge recovery and observation period. Travel insurance policies that cover medical repatriation are strongly recommended, and GAF's coordination team can provide documentation to support insurance claims.
Vertebroplasty achieves clinically meaningful pain relief — defined as a reduction of ≥50% on the Visual Analogue Scale (VAS) or ≥2-point improvement on the Numeric Rating Scale (NRS), with restored or improved functional mobility — in approximately 85–90% of appropriately selected patients. This high success rate applies specifically to patients who meet the evidence-based selection criteria: an acute or subacute vertebral compression fracture (typically ≤6–8 weeks old) with MRI-confirmed bone marrow oedema, pain refractory to conservative management, and no significant posterior cortex breach with canal compromise. The landmark VERTOS IV trial (Lancet, 2018) demonstrated statistically significant superiority of vertebroplasty over sham procedure in this population, with sustained pain relief at 12-month follow-up. In the metastatic vertebral fracture population, success rates for pain control are similarly high (75–85%), particularly when vertebroplasty is combined with radiofrequency ablation or cryoablation of the tumour. The key predictor of success is accurate patient selection — particularly MRI confirmation of active bone marrow oedema at the painful level — which is why GAF Healthcare's pre-procedure imaging review by a senior interventional radiologist is a mandatory step in our patient pathway before travel is confirmed.
Why Plan Your Treatment Through Gaf Healthcare?
GAF Healthcare provides an end-to-end, non-medical coordination service that eliminates the logistical barriers international patients face when seeking vertebroplasty in India or the UAE.
INDIA — VISA & ENTRY: GAF facilitates the e-Medical Visa application for India, which is available to citizens of over 170 countries and can be obtained in as little as 3–5 business days. Our coordination team prepares the mandatory supporting documents: a hospital invitation letter on the treating institution's letterhead, a specialist appointment confirmation, and proof of sufficient funds. The e-Medical Visa allows a stay of up to 60 days with triple-entry privileges, and permits one accompanying attendant (family member or carer) on a separate e-Medical Attendant Visa. GAF's India partner hospitals are NABH-accredited (National Accreditation Board for Hospitals & Healthcare Providers) and JCI (Joint Commission International)-accredited, giving patients the same standards assurance as hospitals in the United States or Western Europe.
UAE — VISA & ENTRY: For patients travelling to Dubai or Abu Dhabi, GAF advises on visa requirements by nationality. Citizens of GCC countries, most Western nations (EU, UK, US, Canada, Australia), and many Asian countries benefit from visa-free entry or visa-on-arrival (30–90 days). Patients from countries requiring advance visa applications are supported by GAF's UAE visa assistance team with hospital-sponsored medical visa letters. UAE partner hospitals are JCI-accredited and licensed by the Dubai Health Authority (DHA) or the Abu Dhabi Department of Health (DoH), providing regulatory assurance equivalent to leading Western healthcare systems.
AIRPORT TRANSFERS & IN-COUNTRY TRANSPORT: GAF arranges private, accessible (wheelchair/stretcher-capable) vehicle transfers from the airport to the hospital and from the hospital to accommodation upon discharge. All vehicles are GPS-tracked and driven by GAF-vetted drivers trained in medical transport assistance. Transport to and from outpatient follow-up appointments is included within the GAF coordination package.
ACCOMMODATION FOR PATIENTS AND ATTENDANTS: GAF has pre-negotiated rates with partner serviced apartments, hospital guesthouses, and hotels within 1–5 km of all partner hospitals in Mumbai, Delhi, Chennai, Bangalore, Hyderabad, Dubai, and Abu Dhabi. Accommodation is selected based on proximity to the hospital, budget, and mobility requirements (e.g., ground-floor or elevator-accessible rooms for patients with acute vertebral fracture pain). Breakfast and in-room meal delivery options are available for the attendant throughout the hospital stay and post-discharge recovery period.
DEDICATED TRANSLATORS & PATIENT COORDINATORS: For patients whose primary language is Arabic, Russian, French, Swahili, Bangla, or other major languages, GAF assigns a dedicated multilingual patient coordinator who is present during key consultations, procedural consent discussions, and discharge planning. Medical interpretation is provided by coordinators with healthcare terminology training — not general interpreters — ensuring clinical accuracy and patient autonomy in decision-making.
TELEMEDICINE FOLLOW-UP: Post-discharge follow-up consultations with the treating interventional radiologist or spine specialist are facilitated via GAF's secure telemedicine platform, allowing patients to complete their recovery monitoring from home without the need for an additional international trip in most cases.